FACTS 001: Characteristics of Participants Enrolled in a Phase III Randomised Controlled Trial of Tenofovir Gel for Prevention of HIV-1 and HSV-2
Date
2014Author
Delany-Moretlwe, Sinead
Smith, Emilee
Myer, Landon
Ahmed, Khatija
Nkala, Busi
Maboa, Rebone
Gama, Cynthia
Sibiya, Sydney
Sebe, Modulakgotla
Brumskine, William
Bekker, Linda-Gail
Nchabeleng, Maposhane
Lombard, Carl
Gray, Glenda
Rees, Helen